Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Mini Reviews in Medicinal Chemistry|July 29, 2004
The second generation of COX-2 inhibitors: clinical pharmacological point of viewD O StichtenothBritish Journal of Rheumatology|May 5, 1998
Nitric oxide and inflammatory joint diseasesD O Stichtenoth, J C FrölichJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 1, 1997
Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteersD O Stichtenoth, B Wagner, J C FrölichMedizinische Klinik (Munich, Germany : 1983)|August 26, 1998
[New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase]D O Stichtenoth, H Zeidler, J C FrölichJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|September 16, 1998
Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteersD O Stichtenoth, B Wagner, J C FrölichEuropean Journal of Clinical Pharmacology|November 9, 2001
Blood donors on medication. Are deferral periods necessary?D O Stichtenoth, H R Deicher, J C FrölichEuropean Journal of Clinical Pharmacology|April 17, 2002
Knowledge on drug dosages of ward physiciansJ U Schnurrer, D O Stichtenoth, J C FrölichAnnals of the Rheumatic Diseases|October 1, 1995
Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisoloneD O Stichtenoth, J Fauler, H Zeidler, et al.Zeitschrift Fur Rheumatologie|January 16, 2016
[DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain]W W Bolten, K Krüger, S Reiter-Niesert, et al.Pageof 3